CBIO Earnings Date: Nov 5, 2026 (Estimated) — Crescent Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is CBIO's next earnings date?
Crescent Biopharma, Inc. (CBIO) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.67 on revenue of $357,143.
How did CBIO do in its last earnings report?
In its most recent report on Jul 30, 2026 (Q2 2026), Crescent Biopharma, Inc. posted EPS of -$0.74 versus the -$0.67 estimate, a miss of 10.4%. Revenue was $0 against a $357,140 estimate. The stock's 1-day post-earnings move was +1.7%.
How much does CBIO stock move after earnings?
CBIO beat EPS estimates in 2 of its last 7 reported quarters. Over the last 8 reports the stock moved an average of 4.0% (up or down) in the day after earnings.
About Crescent Biopharma, Inc.
Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and development of novel cancer therapies. Its investigational portfolio notably includes CR-001, a proprietary bispecific antibody engineered to simultaneously target PD-1 and VEGF pathways for the treatment of solid tumors. The company's pipeline further comprises CR-002 and CR-003. Crescent Biopharma also maintains a strategic alliance with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., focusing on the joint advancement and commercialization of oncology therapeutics, encompassing innovative combination approaches. The company's operations are headquartered in Waltham, Massachusetts.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-30 | Q2 2026 | -0.67 | -0.74 | -10.45% | $0 | ❌ Miss | +1.69% | +6.77% | +20.24% |
| 2026-04-29 | Q1 2026 | -0.80 | -0.70 | +12.50% | $1.0M | ✅ Beat | +6.83% | -13.75% | -1.38% |
| 2026-02-26 | Q4 2025 | -2.58 | -4.01 | -55.43% | $10.8M | ❌ Miss | -1.16% | -8.01% | +8.09% |
| 2025-11-06 | Q3 2025 | -1.23 | -1.27 | -3.25% | $0 | ❌ Miss | +5.39% | +4.99% | +5.15% |
| 2025-07-31 | Q2 2025 | -1.08 | -4.93 | -356.48% | $0 | ❌ Miss | -1.43% | -12.70% | +12.30% |
| 2023-10-26 | Q3 2023 | -0.05 | -0.04 | +20.00% | $0 | ✅ Beat | -8.00% | -93.12% | -91.95% |
| 2023-08-14 | Q2 2023 | -0.07 | -0.07 | +0.00% | $0 | ➖ Inline | +0.61% | -4.27% | -10.98% |
| 2023-05-15 | Q1 2023 | — | 0.01 | — | $0 | — | -6.73% | +0.00% | -15.38% |
Showing last 8 quarters.